The Market Growth Can be Attributed to the Rising Incidences of Diabetes and Growing Awareness Among the Population Regarding Blood Glucose Monitoring.
Glucometers is a medical device that allows the analysis of the blood glucose level of the patient through samples of blood. Due to lack of insulin in the body, the digestion process of the sugar molecules becomes difficult. Increased levels of sugar causes diabetes, and that often leads to various diseases including cardiovascular diseases, eye diseases, urinary infections. Higher sugar levels are also responsible for weakening the immunity of the patient thereby increasing the chances of infectious diseases. Recently dealt pandemic due to widespread COVID-19 virus was one of the infectious diseases that had higher chances of affecting the diabetic population and it increased the death toll multiple times.
Growing Instances of Diabetes Drive Market GrowthGrowing instances of diabetes among the population is majorly driving the growth of the UAE glucometers market in the upcoming five years. In the year 2021, 990.9 people every 1000 people in the country suffered from diabetes. Also, rising geriatric population of the country is also responsible for the growing demand for glucometers. The geriatric population over the age of 65 years is highly susceptible to diabetes. One in every 5 people aging over 69 years suffers from diabetes in the country.
By 2019, over 19% of the adult population aging between 20 years to 79 years were suffering from type II diabetes. Also, the country stands at 10th largest population suffering from diabetes on the world scale. Moreover, the population suffering from diabetes were strictly advised to monitor their health conditions before and after vaccination, since immune system of diabetic patient is drastically affected. Thus, increasing the risks of COVID-19 infection multiple folds.
Technological Advancement Promises Market GrowthGlobal market players are actively invested in research and technological advancement in the medical devices like glucometers. Government’s involvement in promoting the local manufacturers to localize the manufacturing and inviting the global players in the healthcare industry in the country further supports the growth of the UAE glucometers market in the next five years.
Growing demands for the non-invasive techniques & devices, along with the advancements like self-glucose monitoring devices also aid the growth of the UAE glucometers market in the future five years. Furthermore, the common population is actively investing in the better healthcare services and demanding for advanced monitoring devices that can help them keeping a regular check over their health conditions and thus substantiates the growth of the UAE glucometers market in the forecast years through 2027F.
Market SegmentationThe UAE glucometers market is segmented by product type, technique, type, distribution channel, end user, competitional landscape, and regional distribution. Based on product type, the market is differentiated between self-glucose monitoring glucometers and continuous glucose monitoring glucometers. By technique, the market is further differentiated between invasive and non-invasive techniques. Based on type, the market is divided between wearable and non-wearable. By distribution channel, the market is fragmented into hospital pharmacies, retail outlet, online, and others. Based on end user, the market is bifurcated into hospitals & clinics, diagnostic centers, home care, and others. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among Abu Dhabi, Dubai, Sharjah, rest of UAE.
Company ProfileAbbott Laboratories, S.A., Medtronic Meta FZ-LLC, Roche Diagnostics Middle East FZCO, Morepen Laboratories UAE (Dr. Morepen), Ascensia UAE, Beurer UAE, Dexcom UAE, among others is a partial list of major market players of the companies responsible for the growth of UAE glucometers market.
Report Scope:In this report, UAE glucometers market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
UAE Glucometers Market, By Product Type:
- Self-Glucose Monitoring Glucometers
- Continuous Glucose Monitoring Glucometers
UAE Glucometers Market, By Technique:
UAE Glucometers Market, By Type:
UAE Glucometers Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Outlet
UAE Glucometers Market, By End User:
- Hospitals & Clinics
- Diagnostic Centers
- Home Care
UAE Glucometers Market, By Region:
- Abu Dhabi
- Rest of UAE
Competitive LandscapeCompany Profiles: Detailed analysis of the major companies present in UAE glucometers market.
Available Customizations:With the given market data, the publisher offers customizations according to a company’s specific needs.
This product will be delivered within 1-3 business days.
Table of Contents
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (Self Glucose Monitoring Glucometers v/s Continuous Glucose Monitoring Glucometers)
6.2.2. By Technique (Invasive v/s Non-Invasive)
6.2.3. By Type (Wearable v/s Non-Wearable)
6.2.4. By Distribution Channel (Hospital Pharmacies, Retail Outlet, Online, Others)
6.2.5. By End User (Hospitals & Clinics, Diagnostic Centers, Home Care, Others)
6.2.6. By Region
6.2.7. By Company (2021)
6.3. Product Market Map
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technique
7.2.2. By Type
7.2.3. By Distribution Channel
7.2.4. By End User
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technique
8.2.2. By Type
8.2.3. By Distribution Channel
8.2.4. By End User
13.2. Medtronic Meta FZ-LLC
13.3. Roche Diagnostics Middle East FZCO
13.4. Morepen Laboratories UAE (Dr. Morepen)
13.5. Ascensia UAE
13.6. Beurer UAE
13.7. Dexcom UAE
A selection of companies mentioned in this report includes:
- Abbott Laboratories, S.A.
- Medtronic Meta FZ-LLC
- Roche Diagnostics Middle East FZCO
- Morepen Laboratories UAE (Dr. Morepen)
- Ascensia UAE
- Beurer UAE
- Dexcom UAE